overall survival

基本解释

Obviously, the most important endpoint is overall survival.
显然，最重要的终点是总体生存率。
Overall survival after two years was similar among both groups—88% on the drug versus 80% on placebo.
但是两组患者两年后的总存活率相似，服药组为88％，服用安慰剂组为80％。
As noted, however, no significant difference in overall survival was seen between the groups, with a median survival period for each of about 26 months.
然而，正如已经提到的，在各组之间没有看到总体存活率的显著性差异，中值存活期分别为约26个月。

"Women who had their ovaries removed had a decrease in the risk of breast cancer, a decrease in the risk of ovarian cancer and,in addition,they were less likely to die of breast cancer, less likely to die of ovarian cancer and also had an improvement in their overall survival."

The analysis of overall survival (OS), a key secondary endpoint of the study, is event driven.
FORBES: Modified Cold Sore Virus Shrinks Melanoma Tumors, Amgen Says
Both Xtandi and Zytiga, which are pills, have similar overall survival benefit relative to placebo, and quality-of-life data.
FORBES: Connect
Still, given the lack of an overall survival benefit, it might stay in the high 50s for some time.
FORBES: Amgen Drug Prevents Prostate Cancer From Spreading To Bone

总生存率
The 3-year overall survival rate was 66.7%.
3年总生存率是66.7%。
总生存期
However, cisplatin-based therapy showed a trend to benefit in TP53 wild type and to be harmful in TP53 mutated patients (P =0.18 for Overall Survival (OS) and P =0.13 for Disease Free Survival (DFS).
但是,存在一种趋势:顺铂辅助化疗有利于TP53野生型患者的生存,而有害于TP53突变型患者的生存(P=0.18总生存期和P=0.13无病生存期)。
总体存活
In the multivariate analysis,cytology classification, histological type were prognostic factors for local relap se and cervical invasion was prognostic factor for overall survival.
Cox多变量回归分析显示,细胞学分级、组织学类型与子宫内膜癌的复发有关,宫颈是否侵犯与总体存活有关。